8-Benzyl-2,4-diamino-1-phenyl-1,3,5,8-tetraazaspiro[5.5]undeca-2,4-diene hydrochloride

ID: ALA4175173

Chembl Id: CHEMBL4175173

PubChem CID: 145951294

Max Phase: Preclinical

Molecular Formula: C20H25ClN6

Molecular Weight: 348.45

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cl.NC1=NC2(CCCN(Cc3ccccc3)C2)N(c2ccccc2)C(N)=N1

Standard InChI:  InChI=1S/C20H24N6.ClH/c21-18-23-19(22)26(17-10-5-2-6-11-17)20(24-18)12-7-13-25(15-20)14-16-8-3-1-4-9-16;/h1-6,8-11H,7,12-15H2,(H4,21,22,23,24);1H

Standard InChI Key:  YQAGRYCOVVPOBQ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 348.45

Molecular Weight (Monoisotopic): 348.2062

AlogP: 2.13

#Rotatable Bonds: 3

Polar Surface Area: 83.24

Molecular Species: BASE

HBA: 6

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 8.69

CX LogP: 2.99

CX LogD: 1.40

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.89

Np Likeness Score: -0.58

References

1. Francesconi V, Giovannini L, Santucci M, Cichero E, Costi MP, Naesens L, Giordanetto F, Tonelli M..  (2018)  Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).,  155  [PMID:29886325] [10.1016/j.ejmech.2018.05.059]

Source

Source(1):

• Scientific Literature